MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
TAVR in Intermediate-Risk Patients
What the results from ongoing randomized trials may tell us about expanding TAVR to lower-risk patients.
By Arash Arshi, MD, FACC; Daniel R. Watson, MD; and Steven J. Yakubov, MD, FACC
THV Expansion
By Ted E. Feldman, MD, MSCAI, FACC, FESC
Interventional Therapy for Coarctation of the Aorta
A 62-year-old man, with a 20-year history of treatment for essential hypertension with four antihypertensive medications, tripped while on a boat, bumped his head, and fell unconscious into the water.
Device Therapy for Structural Heart Disease
This issue examines device therapy for structural heart disease.
Device Closure for PFO
The data and devices associated with percutaneous PFO closure.
By Gerald Yong, MBBS (Hons), FRACP; Michael H. Salinger, MD, FACC, FSCAI; and Ted E. Feldman, MD, FACC, FSCAI
